Blog
These blog posts explore GP2’s work in further understanding the genetic architecture of Parkinson’s disease.
A letter to the patient community from Randy Schekman, ASAP Scientific Director
By Randy Schekman and Benjamin Stecher | GP2 Values |Learn MoreASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, sha…
A Blueprint for Training and Development in GP2
By Alastair Noyce and Sara Bandres-Ciga | GP2 Values |Learn MoreTraining is a crucial element of GP2. In this blog post, Alastair Noyce, Sara Bandres-Ciga and Emily Fisher outline the program's training and development goal…
Why study disease in different populations?
Learn MoreGP2 aims to revolutionize our understanding of the genetics of Parkinson's disease across populations. Ignacio 'Nacho' Mata explains the importance of involvin…